KMT2A and pulmonary fibrosis: These findings suggest that the expression of KMT2A in lung fibroblasts plays a regulatory role in the development of pulmonary fibrosis, and its deficiency can alleviate fibrosis in the mouse disease model, indicating that KMT2A could be a potential therapeutic target for pulmonary fibrosis.